• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化患者的脂蛋白模式及血浆脂蛋白脂肪酶活性。Lp-X阳性和Lp-X阴性受试者中与HDL2组分增加的关系。

Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.

作者信息

Baldo-Enzi G, Baiocchi M R, Grotto M, Floreani A R, Zagolin M, Chiaramonte M, Cera F, Fellin R

机构信息

Department of Internal Medicine, University of Padua, Italy.

出版信息

Dig Dis Sci. 1988 Oct;33(10):1201-7. doi: 10.1007/BF01536666.

DOI:10.1007/BF01536666
PMID:3168690
Abstract

Plasma lipids, apoprotein A-I and B in serum and in lipoprotein fractions (VLDL + LDL, HDL2, and HDL3) obtained by preparative ultracentrifugation, as well as postheparin lipoprotein lipase activity (H-TGL and LPL) were evaluated in 17 subjects with primary biliary cirrhosis (stage II and III) subdivided into two groups according to the presence or absence of lipoprotein X (Lp-X). A reduction in total lipoprotein lipase activity was observed in both patient groups, compared to controls (P less than 0.01); the hepatic lipoprotein lipase was significantly reduced (P less than 0.01) only in the Lp-X-positive group. The lipid (477.8 +/- 154.3 vs 239.6 +/- 51.1; P less than 0.01) and protein (147.4 +/- 37.1 vs 83.3 +/- 19.7; P less than 0.01) masses in the VLDL + LDL fraction of the Lp-X-positive group were increased compared to controls. In the same group, the HDL2 fraction also showed an increase in lipid (186.6 +/- 80.0 vs 77.9 +/- 21.6; P less than 0.01) and protein (133.9 +/- 60.0 vs 67.9 +/- 16.5; P less than 0.01) masses; in addition, the HDL2 percent lipid composition was different in the two patient groups, showing a decrease in esterified cholesterol (20.4 +/- 3.6 vs 25.7 +/- 2.2; P less than 0.01) and an increase in phospholipids (59.2 +/- 2.9 vs 54.8 +/- 2.6; p less than 0.01) in the Lp-X-positive group.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过制备性超速离心法获得的血清及脂蛋白组分(极低密度脂蛋白+低密度脂蛋白、高密度脂蛋白2和高密度脂蛋白3)中的血浆脂质、载脂蛋白A-I和B,以及肝素后脂蛋白脂肪酶活性(肝甘油三酯脂肪酶和脂蛋白脂肪酶),在17例原发性胆汁性肝硬化(II期和III期)患者中进行了评估,这些患者根据是否存在脂蛋白X(Lp-X)分为两组。与对照组相比,两个患者组的总脂蛋白脂肪酶活性均降低(P<0.01);仅在Lp-X阳性组中,肝脂蛋白脂肪酶显著降低(P<0.01)。与对照组相比,Lp-X阳性组极低密度脂蛋白+低密度脂蛋白组分中的脂质(477.8±154.3对239.6±51.1;P<0.01)和蛋白质(147.4±37.1对83.3±19.7;P<0.01)质量增加。在同一组中,高密度脂蛋白2组分的脂质(186.6±80.0对77.9±21.6;P<0.01)和蛋白质(133.9±60.0对67.9±16.5;P<0.01)质量也增加;此外,两个患者组的高密度脂蛋白2脂质组成百分比不同,Lp-X阳性组的酯化胆固醇减少(20.4±3.6对25.7±2.2;P<0.01),磷脂增加(59.2±2.9对54.8±2.6;P<0.01)。(摘要截短于250字)

相似文献

1
Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.原发性胆汁性肝硬化患者的脂蛋白模式及血浆脂蛋白脂肪酶活性。Lp-X阳性和Lp-X阴性受试者中与HDL2组分增加的关系。
Dig Dis Sci. 1988 Oct;33(10):1201-7. doi: 10.1007/BF01536666.
2
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.
Gastroenterology. 1985 Dec;89(6):1266-78.
3
Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.肝脏疾病和胆汁淤积中的胆固醇酯转移活性及其与脂蛋白脂质脂肪酸组成的关系。
Clin Chim Acta. 1996 Apr 30;248(2):157-74. doi: 10.1016/0009-8981(95)06251-3.
4
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.脂蛋白脂肪酶和肝脂肪酶对极低密度脂蛋白(VLDL)脂解过程中VLDL和高密度脂蛋白(HDL)转化的影响。
Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8.
5
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.肝素后血浆脂蛋白和肝脂酶是低α脂蛋白血症和高α脂蛋白血症的决定因素。
J Lipid Res. 1989 Aug;30(8):1117-26.
6
Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.人乳脂蛋白脂肪酶对人极低密度脂蛋白的脂解降解:将脂蛋白B鉴定为主要的脂蛋白降解产物。
Arch Biochem Biophys. 1986 Jan;244(1):226-37. doi: 10.1016/0003-9861(86)90112-8.
7
Dyslipoproteinaemia of liver disease.肝脏疾病中的脂蛋白异常血症
Baillieres Clin Endocrinol Metab. 1990 Dec;4(4):807-32. doi: 10.1016/s0950-351x(05)80080-1.
8
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].[脂蛋白脂肪酶活性病理性降低与高脂血症发生发展的关系及其对冠心病的意义]
Wien Klin Wochenschr Suppl. 1986;167:1-16.
9
Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.脂蛋白脂肪酶与含载脂蛋白B的脂蛋白的结合。
Biochim Biophys Acta. 1996 Jan 19;1299(2):198-206. doi: 10.1016/0005-2760(95)00209-x.
10
Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.家族性脂蛋白脂肪酶和载脂蛋白C-II缺乏症。7例患者及其一级亲属的脂蛋白和载脂蛋白分析、脂肪组织及肝脏脂蛋白脂肪酶水平
Atherosclerosis. 1983 Oct;49(1):55-68. doi: 10.1016/0021-9150(83)90007-2.

引用本文的文献

1
The liver steatosis severity and lipid characteristics in primary biliary cholangitis.原发性胆汁性胆管炎的肝脂肪变性严重程度和脂质特征。
BMC Gastroenterol. 2021 Oct 22;21(1):395. doi: 10.1186/s12876-021-01974-4.

本文引用的文献

1
Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.用三氯乙酸沉淀法微量测定血浆磷脂
J Lab Clin Med. 1950 Jan;35(1):155-60.
2
The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis.18例原发性胆汁性肝硬化患者血清脂质与皮肤黄瘤的关系。
J Clin Invest. 1949 Nov;28(6 Pt 2):1565-74. doi: 10.1172/JCI102222.
3
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
4
Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.肝内内皮脂肪酶在人体血浆高密度脂蛋白2代谢中作用的证据。
Atherosclerosis. 1980 Aug;36(4):589-93. doi: 10.1016/0021-9150(80)90251-8.
5
Degradation of high density lipoprotein by heparin-releasable liver lipase.肝素可释放肝脂肪酶对高密度脂蛋白的降解作用。
Biochem Biophys Res Commun. 1980 May 14;94(1):101-8. doi: 10.1016/s0006-291x(80)80193-8.
6
Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles.混合胆盐 - 磷脂微团对人胰脂肪酶 - 辅脂酶活性的抑制作用。
Am J Physiol. 1981 Oct;241(4):G328-36. doi: 10.1152/ajpgi.1981.241.4.G328.
7
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.通过简单沉淀法分离和定量人血浆高密度脂蛋白亚类
J Lipid Res. 1982 Nov;23(8):1206-23.
8
Cholestatic lipoproteins--their pathogenesis and significance.胆汁淤积性脂蛋白——其发病机制及意义
Gastroenterology. 1982 Sep;83(3):704-9.
9
Apo A-I and apo A-II inhibit hepatic triglyceride lipase from human postheparin plasma.载脂蛋白A-I和载脂蛋白A-II可抑制人肝素后血浆中的肝甘油三酯脂肪酶。
Biochem Biophys Res Commun. 1981 May 15;100(1):261-6. doi: 10.1016/s0006-291x(81)80091-5.
10
Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis.原发性胆汁性肝硬化患者血浆中高密度脂蛋白浓度升高及血小板聚集性降低。
Atherosclerosis. 1984 Nov;53(2):151-62. doi: 10.1016/0021-9150(84)90191-6.